MARTINELLI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 1.621
EU - Europa 461
AS - Asia 347
OC - Oceania 2
Totale 2.431
Nazione #
US - Stati Uniti d'America 1.616
CN - Cina 173
IT - Italia 111
DE - Germania 96
TR - Turchia 91
SG - Singapore 73
GB - Regno Unito 65
UA - Ucraina 65
SE - Svezia 43
FI - Finlandia 26
BE - Belgio 18
FR - Francia 11
CZ - Repubblica Ceca 8
RU - Federazione Russa 7
CA - Canada 5
IE - Irlanda 3
NL - Olanda 3
AU - Australia 2
ID - Indonesia 2
KR - Corea 2
LT - Lituania 2
AT - Austria 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
JP - Giappone 1
MK - Macedonia 1
MY - Malesia 1
UZ - Uzbekistan 1
Totale 2.431
Città #
Woodbridge 217
Fairfield 208
Ann Arbor 168
Chandler 144
Houston 112
Jacksonville 82
Ashburn 78
Wilmington 71
Seattle 69
Beijing 66
Cambridge 65
Singapore 65
Santa Clara 49
Ferrara 46
Izmir 45
New York 40
Nanjing 31
Milan 24
Shanghai 24
Princeton 22
Boardman 20
Addison 19
Brussels 18
San Diego 17
Munich 14
Bremen 12
Shenyang 11
Brno 8
Nanchang 8
Changsha 7
Frankfurt am Main 7
Helsinki 7
Los Angeles 6
Falls Church 5
London 5
Tianjin 5
Dearborn 4
Jinan 4
Ningbo 4
Toronto 4
Des Moines 3
Dublin 3
Illasi 3
Mountain View 3
Orange 3
Redwood City 3
Auburn Hills 2
Augusta 2
Hebei 2
Hefei 2
Jakarta 2
Jiaxing 2
Norwalk 2
Anzola Dell'emilia 1
Ardabil 1
Bologna 1
Central 1
Colico 1
Hangzhou 1
Hounslow 1
Johor Bahru 1
Kunming 1
La Coruña 1
Lanzhou 1
Leawood 1
Melbourne 1
Monmouth Junction 1
Ottawa 1
Pescara 1
Redmond 1
San Francisco 1
San Mateo 1
Seoul 1
Simi Valley 1
Stockholm 1
Taizhou 1
Torino 1
Trieste 1
Velp 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 1.872
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 164
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 143
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 136
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 133
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 133
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 132
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 130
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 127
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 126
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 125
null 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 120
Delirium in acute promyelocytic leukemia patients: two case reports. 117
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 113
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 98
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 96
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 94
null 88
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 82
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 74
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone 66
Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome 25
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion 22
Totale 2.468
Categoria #
all - tutte 11.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 0 56 47 41 47 46 19 13
2020/2021334 17 19 16 41 19 37 16 34 4 38 62 31
2021/2022287 34 21 11 8 13 17 23 15 8 28 30 79
2022/2023299 29 29 10 46 53 34 24 21 33 0 14 6
2023/2024139 15 13 4 2 4 48 9 7 3 2 0 32
2024/2025187 11 13 44 34 82 3 0 0 0 0 0 0
Totale 2.468